Related Experiment Video
Updated: Jun 30, 2026
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Pioneering of New Generation Therapies for Oral Cancer Involves the Integration of Small Molecules, Nanotechnology,
Ayşe Hale Alkan1, Fatma Zeynep Bozkurt1, Dilara Nur Şengün2
1Biotechnology Institute, Ankara University, Ankara, Türkiye.
Abstract:
Oral cancer remains a significant global health challenge, characterized by high morbidity, poor survival rates, and a tendency for late-stage diagnosis. Although conventional treatment modalities-namely surgery, radiotherapy, and chemotherapy- are partially effective, they are frequently accompanied by substantial functional and aesthetic morbidity, therapeutic resistance, and limited long-term efficacy. In light of these limitations, a paradigm shift is underway in the therapeutic landscape of oral squamous cell carcinoma (OSCC). This shift is driven by three converging innovations: small molecule inhibitors, nanotechnology-based targeted drug delivery systems, and artificial intelligence (AI)-enabled diagnostic and prognostic tools. This review provides a comprehensive synthesis of recent preclinical and clinical advancements in these areas, emphasizing their underlying mechanisms, therapeutic benefits, and potential for synergy. Small molecule therapies modulate oncogenic signaling cascades in a pathway-specific manner, while nanocarrier platforms deliver cytotoxic and immunomodulatory agents precisely and locally, thereby reducing systemic toxicity. Concurrently, AI-driven models are transforming early detection, risk stratification, and outcome prediction by leveraging high-throughput omics data and imaging analytics. Together, these transformative technologies represent a significant advancement in precision oncology and underscore the importance of translating laboratory innovations into clinical applications. This review critically evaluates these emerging strategies, highlighting the potential of an interdisciplinary approach to redefine therapeutic standards and overcome long-standing clinical challenges in oral cancer management.
Insights
New oral cancer treatments combine small molecule inhibitors, nanotechnology, and artificial intelligence (AI) for better precision oncology. These innovations aim to improve early detection, targeted drug delivery, and patient outcomes in oral squamous cell carcinoma (OSCC) management.
Area of Science:
- Oncology
- Biotechnology
- Medical Informatics
Background:
- Oral cancer, particularly oral squamous cell carcinoma (OSCC), presents significant global health challenges with high morbidity and poor survival rates.
- Conventional treatments like surgery, radiotherapy, and chemotherapy have limitations including toxicity, resistance, and suboptimal long-term efficacy.
- Late-stage diagnosis is a major contributing factor to poor outcomes in oral cancer.
Purpose of the Study:
- To synthesize recent preclinical and clinical advancements in oral cancer therapeutics.
- To explore the synergistic potential of small molecule inhibitors, nanotechnology, and artificial intelligence (AI) in OSCC management.
- To highlight the transition towards precision oncology for oral cancer.
Main Methods:
- Review of recent preclinical and clinical advancements in small molecule inhibitors, nanotechnology-based drug delivery, and AI-enabled diagnostics for OSCC.
- Analysis of the mechanisms of action, therapeutic benefits, and synergistic potential of these emerging technologies.
- Evaluation of AI applications in early detection, risk stratification, and outcome prediction using omics data and imaging analytics.
Main Results:
- Small molecule therapies offer pathway-specific modulation of oncogenic signaling.
- Nanocarrier platforms enable precise, local delivery of agents, reducing systemic toxicity.
- AI models demonstrate transformative potential in early detection, risk stratification, and outcome prediction for OSCC.
Conclusions:
- Converging innovations in small molecule inhibitors, nanotechnology, and AI represent a significant advancement in oral cancer precision oncology.
- These technologies hold promise for overcoming long-standing clinical challenges in OSCC management.
- An interdisciplinary approach is crucial for translating laboratory innovations into effective clinical applications for oral cancer.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...